Nunez Nicolas A, Coombes Brandon J, Romo-Nava Francisco, Bond David J, Vande Voort Jennifer, Croarkin Paul E, Leibman Nicole, Gardea Resendez Manuel, Veldic Marin, Betcher Hannah, Singh Balwinder, Colby Colin, Cuellar-Barboza Alfredo, Prieto Miguel, Moore Katherine M, Ozerdem Aysegul, McElroy Susan L, Frye Mark A, Biernacka Joanna M
Department of Psychiatry & Psychology, Mayo Clinic, Rochester, MN, United States.
Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, United States.
Front Psychiatry. 2022 Apr 14;13:884217. doi: 10.3389/fpsyt.2022.884217. eCollection 2022.
Bipolar disorder (BD) with co-occurring attention deficit-hyperactivity disorder (ADHD) is associated with an unfavorable course of illness. We aimed to identify potential clinical and genetic correlates of BD with and without ADHD.
Among patients with BD ( = 2,198) enrolled in the Mayo Clinic Bipolar Biobank we identified those with ADHD diagnosed in childhood (BD+cADHD; = 350), those with adult-onset attention deficit symptoms (BD+aAD; = 254), and those without ADHD ( = 1,594). We compared the groups using linear or logistic regression adjusting for age, sex, and recruitment site. For genotyped patients ( = 1,443), logistic regression was used to compare ADHD and BD polygenic risk scores (PRSs) between the BD groups, as well as to non-BD controls ( = 777).
Compared to the non-ADHD BD group, BD+cADHD patients were younger, more often men and had a greater number of co-occurring anxiety and substance use disorders (all < 0.001). Additionally, BD+cADHD patients had poorer responses to lithium and lamotrigine ( = 0.005 and = 0.007, respectively). In PRS analyses, all BD patient subsets had greater genetic risk for BD and ADHD when compared to non-BD controls ( < 0.001 in all comparisons). BD+cADHD patients had a higher ADHD-PRS than non-ADHD BD patients ( = 0.012). However, BD+aAD patients showed no evidence of higher ADHD-PRS than non-ADHD BD patients ( = 0.38).
BD+cADHD was associated with a greater number of comorbidities and reduced response to mood stabilizing treatments. The higher ADHD PRS for the BD+cADHD group may reflect a greater influence of genetic factors on early presentation of ADHD symptoms.
双相情感障碍(BD)合并注意缺陷多动障碍(ADHD)与不良病程相关。我们旨在确定伴或不伴ADHD的BD的潜在临床和遗传相关性。
在梅奥诊所双相情感障碍生物样本库登记的BD患者(n = 2198)中,我们确定了童年期诊断为ADHD的患者(BD + cADHD;n = 350)、成年期出现注意缺陷症状的患者(BD + aAD;n = 254)以及无ADHD的患者(n = 1594)。我们使用线性或逻辑回归对年龄、性别和招募地点进行调整后比较各组。对于基因分型患者(n = 1443),使用逻辑回归比较BD组之间以及与非BD对照组(n = 777)的ADHD和BD多基因风险评分(PRSs)。
与非ADHD的BD组相比,BD + cADHD患者更年轻,男性更常见,同时出现焦虑和物质使用障碍的数量更多(均P < 0.001)。此外,BD + cADHD患者对锂盐和拉莫三嗪的反应较差(分别为P = 0.005和P = 0.007)。在PRS分析中,与非BD对照组相比,所有BD患者亚组患BD和ADHD的遗传风险更高(所有比较中P < 0.001)。BD + cADHD患者的ADHD - PRS高于非ADHD的BD患者(P = 0.012)。然而,BD + aAD患者没有证据表明其ADHD - PRS高于非ADHD的BD患者(P = 0.38)。
BD + cADHD与更多的共病以及对心境稳定剂治疗的反应降低相关。BD + cADHD组较高的ADHD PRS可能反映了遗传因素对ADHD症状早期表现的更大影响。